Skip to main content

Table 3 Health-related Quality of Life according to the number of PEP session attendance

From: Increased number of structured diabetes education attendance was not associated with the improvement in patient-reported health-related quality of life: results from Patient Empowerment Programme (PEP)

  

PEP session attendance

  

HRQOL

1 (n = 25)

2 (n = 49)

3-6 (n = 41)

≥7 (n = 64)

P-value*

 

Change in SF-12v2

     
 

PF

−3.8 ± 16.9

3.5 ± 21.4

2.3 ± 21.0

0.8 ± 23.6

0.546

 
 

RP

−7.2 ± 23.2

1.3 ± 15.0

−2.3 ± 17.9

3.3 ± 24.4

0.137

 
 

BP

8.7 ± 33.1

13.5 ± 27.8

−1.2 ± 22.7

3.9 ± 29.6

0.081

 
 

GH

−11.7 ± 25.3

0.1 ± 24.8

−5.6 ± 33.8

−2.0 ± 30.4

0.360

 
 

VT

1.9 ± 27.3

4.0 ± 23.9

1.8 ± 27.3

5.5 ± 25.4

0.881

 
 

SF

−3.8 ± 32.9

0.0 ± 12.4

−1.7 ± 18.4

5.5 ± 24.6

0.203

 
 

RE

−1.0 ± 16.6

5.5 ± 14.3

−2.0 ± 15.9

5.1 ± 18.9

0.063

 
 

MH

−4.0 ± 23.0

3.3 ± 14.4

−1.5 ± 14.1

1.4 ± 18.4

0.294

 
 

PCS

−1.5 ± 9.2

1.9 ± 7.7

−0.4 ± 7.0

0.4 ± 9.5

0.374

 
 

MCS

−0.8 ± 10.8

1.3 ± 6.9

−0.9 ± 7.7

2.1 ± 9.6

0.249

 

Change in SF-6D

0.000 ± 0.139

0.064 ± 0.106

0.001 ± 0.110

0.024 ± 0.134

0.059

 
  

Generic session attendance

DM-specific session attendance

P-value**

  

Non-attendees

Attendees

Non-attendees

Attendees

 

DM-specific

HRQOL

0 (n = 23)

≥1 (n = 156)

0 (n = 29)

≥1 (n = 150)

Generic

Change in SF-12v2

     
 

PF

4.3 ± 19.4

0.8 ± 21.8

−5.0 ± 15.3

2.5 ± 22.4

0.458

0.083

 

RP

3.3 ± 10.1

−0.5 ± 21.8

−9.6 ± 24.5

1.8 ± 19.4

0.411

0.006

 

BP

19.6 ± 31.9

4.1 ± 27.5

5.0 ± 26.6

6.3 ± 29.0

0.015

0.827

 

GH

0.4 ± 17.5

−4.2 ± 30.5

−7.7 ± 27.2

−2.8 ± 29.5

0.476

0.408

 

VT

3.3 ± 23.0

3.8 ± 26.0

−1.7 ± 26.2

4.8 ± 25.4

0.929

0.208

 

SF

−4.3 ± 9.7

1.7 ± 23.3

−3.3 ± 31.3

1.8 ± 19.9

0.220

0.247

 

RE

2.7 ± 10.6

2.7 ± 17.6

−2.1 ± 19.7

3.6 ± 16.2

0.987

0.093

 

MH

2.7 ± 17.7

0.2 ± 17.2

1.3 ± 22.2

0.3 ± 16.2

0.508

0.784

 

PCS

3.3 ± 7.3

−0.1 ± 8.6

−2.7 ± 7.3

1.0 ± 8.6

0.073

0.032

 

MCS

−0.3 ± 8.5

0.9 ± 8.8

0.4 ± 9.8

0.9 ± 8.5

0.517

0.781

Change in SF-6D

0.086 ± 0.109

0.017 ± 0.124

−0.011 ± 0.138

0.033 ± 0.120

0.012

0.077

  1. Note:
  2. PEP Patient Empowerment Programme, HRQOL Health-related Quality of Life, PF Physical Functioning, RP Role Physical, BP Bodily Pain, GH General Health, VT Vitality, SF Social Functioning, RE Role Emotional, MH Mental Health, PCS Physical Composite Summary, MCS Mental Composite Summary
  3. *P-value of testing significance using one-way ANOVA
  4. **P-value of testing significance between non-attendees and attendees using paired t-test
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us